Doctor's name here
Ph.D. in Pharmacy Practice, 2014 in The Tamilnadu Dr.M.G.R Medical University, Chennai, Tamilnadu, India.
M.Pharm in Pharmacy Practice, 2007 in The Tamilnadu Dr.M.G.R Medical University, Chennai, Tamilnadu, India.
B.Pharm, 2002 in The Tamilnadu Dr.M.G.R Medical University, Chennai, Tamilnadu, India.
AREA OF EXPERTISE AS PHARMACY PRACTICE PRECEPTOR IN HOSPITAL
Ward round participation with physician and students in
General medicine, Neurology, Endocrinology, Cardiology, Surgery etc.
Medication safety management
Pharmaceutical care practice
Drug Information Centre
Clinical pharmacy research
Patient interviewing and counseling
AREAS OF RESEARCH INTEREST
- Cognitive impairment in epilepsy
- Type 2 diabetes mellitus prevalence and complications
- Antibiotic sensitivity pattern
- Antibiotic cost effective analysis
- Editorial board member in MedEdu Tabuk Newsletter, Tabuk, KSA.
- Registered Pharmacist, Saudi Commission for Health Specialties, Saudi Arabia.
- Life Member, Indian Pharmacist Association.
- Registered Pharmacist, Tamilnadu State Pharmacy Council, India.
- Editorial board member in "Clinical Endocrinology & Metabolic Disorders"
- Editorial board member in “Journal of Human Endocrinology”.
- Member of Institution Ethics Committee, Erode Cancer Centre, Erode, Tamilnadu, India
- Examiner for B.Pharm, Pharm.D and Ph.D at the Tamilnadu Dr.M.G.R Medical University, Chennai, Tamilnadu, India.
Total number of research papers published - 20
Total number of books published - 2
Community services offered
- Health awareness program using audio-visual aids on communicable diseases, hypertension, diabetes mellitus, asthma, hyperlipidaemia conducted on 10,000 Students in Vivekanandha group of educational institutions, Tiruchengode, Tamilnadu, India during pharmacy week celebrations in 2008.
- Awareness program on environmental safety, global warming and protection from swine-flu, bird-flu organized for school students in Tiruchengode taluk, Tamilnadu, India surrounding area schools in 2009.
- Community health awareness program at Disha Medicals, Tiruchengode, Tamilnadu, India was conducted to assess BMI, waist/ hip ratio, BP, blood glucose, patient counseling and distribution of handouts on diseases and treatment in connection with pharmacy week celebrations during the month of November 2010.
- Health screening program on hypertension, obesity, diabetes, cancer etc. conducted in village population in Tiruchengode, Tamilnadu, India in November 2011.
- Community health awareness program organized in urban and rural population of Tircuchengode, Tamilnadu, India to educate about dengue fever, to distribute pamphlets among the public and risk assessment for cardiovascular diseases and breast cancer in November 2012.
|Sunday||Office hours|| |
Applied Drug Information (L) PDPP562
IPPE 1 (L)
Pharmacy Practice Experience (Tr.)
Pharmacy Practice Experience (Tr.)
|Wednesday||Advanced Therapeutics 2 (Tr.) PDPP534||Advanced Therapeutics 2 (Tr.) PDPP534|| |
|Advanced Therapeutics 1 (Tr.) PDPP533||Advanced Therapeutics 1 (Tr.) PDPP533|
|Advanced Therapeutics 2 (L) PDPP534||Advanced Therapeutics 2 (L) PDPP534||Advanced Therapeutics 2 (L) PDPP534|
Comparison of Montreal Cognitive Assessment (MOCA) with Mini Mental State Examination (MMSE) on association between homocysteine and cognitive status in epilepsy patients with phenytoin monotherapy
Assessment of patient medication adherence among the type 2 diabetes mellitus population with peripheral diabetic neuropathy in South India
Results: Of the 120 screened subjects, 86 patients were included in the present study. A majority (76.7%) were overweight, and 51% had DM for the past 11e15 years. ANOVA was used to compare patients’ glycaemic status, peripheral diabetic neuropathy screening and medication adherence in all three follow-up visits, and p < 0.0001 was considered as significant. Significant improvement in medication adherence and reduction of the peripheral diabetic neuropathy severity (p < 0.0001) were observed from patients’ first to third visits.
Phenytoin induced cognitive impairment in patients with epilepsy
Epilepsy is a common episodic neurological condition characterized by seizures. WHO estimates that 4 to 10 per 1000 worldwide have this disease. It is not clearly established whether cognitive impairment is due to either seizure or anti-epileptic drugs. Previous studies already reported the relationship between homocysteine and cognitive status. The present study aimed to investigate the mechanisms involved in the cognitive impairment in patients with epilepsy on phenytoin monotherapy. A prospective case-control study was carried out in a hospital in India. Newly diagnosed epilepsy patients were the controls; Whereas, Epilepsy patients on phenytoin monotherapy were the cases. Key finding suggests that cases have mild hyperhomocysteinemia when compared with controls. Homocysteine has significant negative correlation (P<0.05) with cognitive status among the cases. The present study recommends the routine assessment of homocysteine level in epilepsy patients on phenytoin monotherapy in order to protect this population from severe cognitive impairment which may ultimately progress to Alzheimer’s disease.
Book available in Noor publishing
Association of apolipoprotein E ?4 allele with cognitive impairment in patients with epilepsy and interaction with phenytoin monotherapy
Comparative assessment of Montreal Cognitive Assessment (MOCA) and Minimental State Examination (MMSE) in apolipoprotein E (APOE) e4 allele carriers in epilepsy